AIDS

1. NAIK V, Nekkalapudi A, Boopathy AV, Falkard B, et al
   Emergence of in vitro resistance to lenacapavir is similar across HIV-1 subtypes.
   AIDS. 2025 Sep 18. doi: 10.1097/QAD.0000000000004334.
   

   >> Share

   
   

   
   Am J Trop Med Hyg

2. BAJRACHARYA S, Basnet A, Shrestha RB, Adhikari J, et al
   A Retrospective Analysis of Bacterial Infections (2021-2024) in a Reference Laboratory in Kathmandu, Nepal.
   Am J Trop Med Hyg. 2025;113:749-757.
   

   >> Share

   
   
3. NTAGWABIRA E, Mugiraneza J, Nizeyimana P, Ngangali JP, et al
   Surveillance of Common Circulating Enteric Bacteria and Antimicrobial Susceptibility Patterns in Five Satellite Laboratories in Rwanda, 2014-2022.
   Am J Trop Med Hyg. 2025;113:744-748.
   

   >> Share

   
   
4. GHIMIRE R, Thakur SK, Thapa Shrestha U, Rijal KR, et al
   Investigation of the blaNDM-1 and armA Genes in Carbapenem-Resistant Klebsiella pneumoniae Isolated from the Clinical Samples in Kathmandu, Nepal.
   Am J Trop Med Hyg. 2025 Sep 25:tpmd250433. doi: 10.4269/ajtmh.25-0433.
   

   >> Share

   
   
5. NYGREN D, Andersson F, Barrow E, Bittaye SO, et al
   Bloodstream Infections and Antimicrobial Resistance in The Gambia: Continuous Surveillance from a Tertiary Care Center.
   Am J Trop Med Hyg. 2025 Sep 23:tpmd250199. doi: 10.4269/ajtmh.25-0199.
   

   >> Share

   
   

   
   Antimicrob Agents Chemother

6. ZENG Q, Huang H, Lu J, Wu L, et al
   Comparison of different colistin sulfate regimens for carbapenem-resistant gram-negative bacteria pneumonia in neurocritical care patients: a retrospective cohort study.
   Antimicrob Agents Chemother. 2025 Sep 22:e0064425. doi: 10.1128/aac.00644.
   

   >> Share

   
   
7. PETERSEN S, Diricks M, Utpatel C, Schulenburg H, et al
   Evolution of beta-lactam resistance causes fitness reductions and several cases of collateral sensitivities in the human pathogen Haemophilus influenzae.
   Antimicrob Agents Chemother. 2025 Sep 22:e0057625. doi: 10.1128/aac.00576.
   

   >> Share

   
   
8. BARKER KS, Santana DJ, Zhang Q, Peters TL, et al
   Mutations in TAC1B drive increased CDR1 and MDR1 expression and azole resistance in Candida auris.
   Antimicrob Agents Chemother. 2025 Aug 18:e0030025. doi: 10.1128/aac.00300.
   

   >> Share

   
   
9. REITLER P, DeJarnette CA, Kumar R, Tucker KM, et al
   A screen to identify antifungal antagonists reveals a variety of pharmacotherapies that induce echinocandin tolerance in Candida albicans.
   Antimicrob Agents Chemother. 2025 Aug 18:e0048425. doi: 10.1128/aac.00484.
   

   >> Share

   
   
10. LAI Y-T, Dingens AS, DeMouth M, Helmold Hait S, et al
    Fostemsavir analog BMS-818251 has enhanced viral neutralization potency and similar escape mutation profile.
    Antimicrob Agents Chemother. 2025 Aug 27:e0191024. doi: 10.1128/aac.01910.
    

    >> Share

    
    
11. WANG C, Huang H, Valera L, Parcella K, et al
    Preclinical virology profiles of the HIV-1 capsid inhibitors VH4004280 and VH4011499.
    Antimicrob Agents Chemother. 2025 Sep 3:e0030925. doi: 10.1128/aac.00309.
    

    >> Share

    
    
12. WAN T-W, Shintani M, Kojima KK, Moriguchi N, et al
    Transposition of Tn552-II (a Tn552 derivative) to the conjugative pCtra plasmid family in pediatric multidrug-resistant community-associated MRSA.
    Antimicrob Agents Chemother. 2025;69:e0064725.
    

    >> Share

    
    
13. ALARCON RIOS AC, Zwep LB, Vriesendorp B, Knibbe CAJ, et al
    Colistin resistance dynamics in Pseudomonas aeruginosa under biofilm and planktonic growth.
    Antimicrob Agents Chemother. 2025;69:e0042125.
    

    >> Share

    
    
14. SCANGARELLA-OMAN NE, Butler DL, Breton J, Brown D, et al
    Efficacy and in vitro activity of gepotidacin against bacterial uropathogens, including drug-resistant phenotypes, in females with uncomplicated urinary tract infections: results from two global, pivotal, phase 3 trials (EAGLE-2 and EAGLE-3).
    Antimicrob Agents Chemother. 2025 Sep 9:e0164024. doi: 10.1128/aac.01640.
    

    >> Share

    
    
15. SCANGARELLA-OMAN NE, Butler DL, Breton J, Brown D, et al
    Efficacy and in vitro activity of gepotidacin against bacterial uropathogens, including subsets with molecularly characterized resistance mechanisms and genotypes/epidemiological clones, in females with uncomplicated urinary tract infections: results
    Antimicrob Agents Chemother. 2025 Sep 9:e0163924. doi: 10.1128/aac.01639.
    

    >> Share

    
    
16. RAKA V, Jangra M, Kaur P, Dadwal R, et al
    Preclinical evaluation of tridecaptin M: in vitro and in vivo efficacy against colistin-resistant Gram-negative bacterial pathogens and pharmacokinetics.
    Antimicrob Agents Chemother. 2025;69:e0108325.
    

    >> Share

    
    
17. TURNER AM, Kinsella P, Miller WR, Carter GP, et al
    Therapeutic approach to difficult-to-treat multidrug-resistant enterococcal infections.
    Antimicrob Agents Chemother. 2025 Sep 11:e0106024. doi: 10.1128/aac.01060.
    

    >> Share

    
    
18. MARTIN-VICENTE A, Nywening AV, Xie J, Thorn HI, et al
    Genetic analysis of common triazole resistance mechanisms in a collection of Aspergillus lentulus clinical isolates from the United States.
    Antimicrob Agents Chemother. 2025 Sep 12:e0069025. doi: 10.1128/aac.00690.
    

    >> Share

    
    
19. DONG X, Xiang Y, Li Y, Zhang Y, et al
    Lineage-specific evolution and resistance-virulence divergence in Klebsiella pneumoniae ST268: a global population genomic analysis.
    Antimicrob Agents Chemother. 2025;69:e0070325.
    

    >> Share

    
    

    
    Clin Infect Dis

20. POGUE JM, Kaye KS
    Actually, it may be time to return to colistin and meropenem in some patients infected with Carbapenem-resistant A. baumannii (CRAB).
    Clin Infect Dis. 2025 Sep 26:ciaf534. doi: 10.1093.
    

    >> Share

    
    
21. MARAOLO AE, Ceccarelli G
    It is time to go beyond the association between colistin and meropenem for invasive carbapenem-resistant Acinetobacter baumannii infections.
    Clin Infect Dis. 2025 Sep 26:ciaf533. doi: 10.1093.
    

    >> Share

    
    
22. TAWEESUK A, Rattanaumpawan P, Rachakhom S, Wangchinda W, et al
    Cluster-randomized Controlled Trial of Enhanced Carbapenem-resistant Enterobacterales Prevention Program in General Medicine Wards, Siriraj Hospital.
    Clin Infect Dis. 2025 Sep 22:ciaf523. doi: 10.1093.
    

    >> Share

    
    

    
    Emerg Infect Dis

23. MIZUSHIMA H, Komori M, Yoshida CA, Miyairi I, et al
    Neonatal Gonococcal Conjunctivitis Caused by Fluoroquinolone-Resistant Neisseria gonorrhoeae.
    Emerg Infect Dis. 2025;31:2043-2045.
    

    >> Share

    
    
24. CARTEE JC, Cherdtrakulkiat T, Joseph SJ, Kittiyaowamarn R, et al
    Antimicrobial-Resistant Clonal Complex 11 Neisseria meningitidis-Associated Urethritis Cluster, Thailand.
    Emerg Infect Dis. 2025;31:1992-1997.
    

    >> Share

    
    
25. PERRY J, Rakler T, Arnold K, Wiseman A, et al
    Multidrug-Resistant pESI-Harboring Salmonella enterica Serovar Muenchen Sequence Type 82 in Poultry and Humans, Israel, 2020-2023.
    Emerg Infect Dis. 2025;31:1969-1979.
    

    >> Share

    
    
26. RABAULT C, Shuping L, Mpembe R, Quan V, et al
    Recent Systemic Antifungal Exposure and Nonsusceptible Candida in Hospitalized Patients, South Africa, 2012-2017.
    Emerg Infect Dis. 2025;31:1901-1911.
    

    >> Share

    
    

    
    Int J Antimicrob Agents

27. SONG Y, Li J, Zhang Y, Su L, et al
    Biofilm Maturation in Carbapenem-resistant Pseudomonas aeruginosa Is Regulated by the sRNA PA213 and Its Corresponding Encoded Small Protein.
    Int J Antimicrob Agents. 2025 Sep 18:107625.
    

    >> Share

    
    
28. CURRY BN, Singh N, Gross AE, Watkins JV, et al
    Pharmacodynamic Insights to Support Pneumonia Treatment in a Patient Co-Infected with Two Carbapenem-Resistant Bacteria.
    Int J Antimicrob Agents. 2025 Sep 25:107633.
    

    >> Share

    
    
29. LIU C, Du P, Yang P, Tang Y, et al
    Long-distance transmission of tmexCD1-toprJ1 positive Klebsiella pneumoniae between humans and food animals.
    Int J Antimicrob Agents. 2025;66:107566.
    

    >> Share

    
    
30. ZHANG J, Wang H, Ni Y, Yan Z, et al
    Comparative epidemiology and resistance mechanisms of carbapenem-, tigecycline-, and polymyxin-resistant Enterobacteriaceae in pediatric diarrhea: A cross-sectional study in 2017 and 2023.
    Int J Antimicrob Agents. 2025;66:107580.
    

    >> Share

    
    
31. JO DM, Oh DK, Cho KJ, Tabassum N, et al
    Understanding the role of drug efflux pumps in biofilms and virulence properties: Multiple potential strategies controlling bacterial infections.
    Int J Antimicrob Agents. 2025;66:107584.
    

    >> Share

    
    

    
    J Antimicrob Chemother

32. GIARRATANA LR, Pirolo M, Roch FF, Conrady B, et al
    Evolving landscape of methicillin-resistant Staphylococcus pseudintermedius: the emergence of new epidemic waves across Europe, Asia and North America.
    J Antimicrob Chemother. 2025 Sep 27:dkaf340. doi: 10.1093.
    

    >> Share

    
    
33. HSU CH, Li C, Harrison L, Zhao S, et al
    Genomic structure of class 1 and 2 integrons in non-typhoidal Salmonella isolated from food animals and related meat products in the USA.
    J Antimicrob Chemother. 2025;80:2844-2853.
    

    >> Share

    
    
34. YANG J, Jiang T, Zhang M, Xue J, et al
    Phenotypic and genotypic profiles of clinical isolates of various Nocardia species to carbapenems and fluoroquinolones.
    J Antimicrob Chemother. 2025;80:2862-2872.
    

    >> Share

    
    
35. LARKIN C, Valappil SP, Palanisamy N
    Global prevalence of nitrofurantoin-resistant uropathogenic Escherichia coli (UPEC) in humans: a systematic review and meta-analysis.
    J Antimicrob Chemother. 2025;80:2609-2621.
    

    >> Share

    
    
36. HALIM J, Keane AP, Bouzo J, Aderibigbe T, et al
    Synergistic cefiderocol-containing antibiotic combinations active against highly drug-resistant Acinetobacter baumannii patient isolates with diverse resistance mechanisms.
    J Antimicrob Chemother. 2025;80:2814-2824.
    

    >> Share

    
    
37. ZAGHI I, Cricca M, Roberts JA, Brandolini M, et al
    Development of blood culture time-to-positivity as a pharmacodynamic indicator for monitoring antibiotic therapy against MDR Gram-negative bacteria.
    J Antimicrob Chemother. 2025;80:2705-2713.
    

    >> Share

    
    
38. BALAKUNTLA J, Simjee S, Mane SP, Tice G, et al
    Distinct population structure and genomic context of NarAB between broiler and human clinical Enterococcus isolates.
    J Antimicrob Chemother. 2025 Aug 7:dkaf296. doi: 10.1093.
    

    >> Share

    
    
39. SKOVMAND S, Norgaard C, Salado-Rasmussen K, Jensen JS, et al
    In vitro activity of thiamphenicol against drug-susceptible and drug-resistant strains of Mycoplasma genitalium.
    J Antimicrob Chemother. 2025;80:2676-2681.
    

    >> Share

    
    
40. CINCOTTA SE, Ostrowsky BE, Howard-Anderson J, Beekmann SE, et al
    Treatment preferences by infectious diseases clinicians for carbapenem-resistant Enterobacterales infections.
    J Antimicrob Chemother. 2025 Sep 30:dkaf371. doi: 10.1093.
    

    >> Share

    
    
41. IACHKINE J, Alexandre K, Marlat C, Briant A, et al
    Temocillin versus other intravenous beta-lactams for urinary tract infections caused by third-generation cephalosporin-resistant Enterobacterales: a multicentre retrospective matched cohort study.
    J Antimicrob Chemother. 2025 Sep 30:dkaf370. doi: 10.1093.
    

    >> Share

    
    
42. WITKOWSKA A, Biedrzycka M, Izdebski R, Literacka E, et al
    Assessment of an LC coupled with tandem MS (LC-MS/MS) tool in the detection of antimicrobial resistance mechanisms in Enterobacterales.
    J Antimicrob Chemother. 2025 Sep 24:dkaf339. doi: 10.1093.
    

    >> Share

    
    
43. ELADAWY M, Heslop N, Negus D, Thomas JC, et al
    Phenotype-genotype discordance in antimicrobial resistance profiles of Gram-negative uropathogens recovered from catheter-associated urinary tract infections in Egypt.
    J Antimicrob Chemother. 2025 Sep 23:dkaf352. doi: 10.1093.
    

    >> Share

    
    
44. YANG P, Liu C, Zheng J, Yi J, et al
    Rapid replacement of blaKPC variant in ST11 carbapenem-resistant and hypervirulent Klebsiella pneumoniae contributed to ceftazidime/avibactam resistance during severe in vivo infection.
    J Antimicrob Chemother. 2025 Sep 18:dkaf337. doi: 10.1093.
    

    >> Share

    
    

    
    J Clin Microbiol

45. BRANDAO AP, Ferreira FMdA, Simeao FCdS, Ferrazoli L, et al
    Off-label evaluation of the BD MAX MDR-TB assay for rapid diagnosis of rifampicin and isoniazid resistance of Mycobacterium tuberculosis clinical isolates in a high-volume reference laboratory.
    J Clin Microbiol. 2025 Sep 23:e0091225. doi: 10.1128/jcm.00912.
    

    >> Share

    
    

    
    J Infect Chemother

46. MIYAZAKI N, Kurumiya A, Takayama M, Kawamoto Y, et al
    Efficacy of Hydrogen Peroxide Vaporizing Against Methicillin-Resistant Staphylococcus aureus, Extended-Spectrum beta-Lactamase-Producing Bacteria, and Clostridioides difficile.
    J Infect Chemother. 2025 Sep 26:102820. doi: 10.1016/j.jiac.2025.102820.
    

    >> Share

    
    
47. ISHIWADA N, Nishi J, Fujimaki K, Takahashi S, et al
    Nationwide surveillance of bacterial pathogens isolated from children by the surveillance committee of the Japanese society of chemotherapy, Japanese association for infectious diseases, and Japanese society for clinical microbiology between April 202
    J Infect Chemother. 2025;31:102812.
    

    >> Share

    
    
48. TAKAHASHI J, Yajima T, Kawaguchiya M, Hashimoto N, et al
    Nosocomial outbreak of multidrug-resistant Streptococcus pneumoniae serotype 15A (non-vaccine serotype) in a community hospital.
    J Infect Chemother. 2025;31:102811.
    

    >> Share

    
    
49. TOKIMATSU I, Fujikura Y, Matsumoto T, Tsukada H, et al
    Nationwide surveillance of antibacterial susceptibility in bacterial respiratory pathogens in Japan, 2022-2023.
    J Infect Chemother. 2025;31:102781.
    

    >> Share

    
    

    
    J Infect Dis

50. GONTJES KJ, Singh A, Sansom SE, Boyko JD, et al
    Phylogenetic context of antibiotic resistance provides insights into the dynamics of resistance emergence and spread.
    J Infect Dis. 2025 Sep 15:jiaf478. doi: 10.1093.
    

    >> Share

    
    
51. SRIDHAR S, Worby CJ, Bronson RA, Turbett SE, et al
    Insights Into Global Antimicrobial Resistance Dynamics Through the Sequencing of Enteric Bacteria From US International Travelers.
    J Infect Dis. 2025 Sep 24:jiaf469. doi: 10.1093.
    

    >> Share

    
    
52. PORETSKY RS, Gonzalez DS, Horton A, Schoeny M, et al
    Establishing a Practical Approach to Sewer Monitoring for Antimicrobial Resistance Genes and Organisms at Healthcare Facilities.
    J Infect Dis. 2025 Sep 24:jiaf434. doi: 10.1093.
    

    >> Share

    
    
53. BUSTION AE, Ernest JP, Kaya F, Silva C, et al
    The kinetics of bedaquiline diffusion in tuberculous cavities open a window for emergence of resistance.
    J Infect Dis. 2025 Jun 4:jiaf303. doi: 10.1093.
    

    >> Share

    
    

    
    J Med Microbiol

54. GRIGORUTA DG, Poh CJ, Rodwell EV, Crewdson A, et al
    Surveillance of genomic diversity and antimicrobial resistance in enterotoxigenic Escherichia coli in England, 2015-2023.
    J Med Microbiol. 2025;74.
    

    >> Share

    
    
55. HILLIAM Y, Armstrong SD, Langendonk RF, Kaye S, et al
    Induction of lipid A modification genes in Pseudomonas aeruginosa cells tolerant to a commercially available contact lens disinfection solution.
    J Med Microbiol. 2025;74:002073.
    

    >> Share

    
    

    
    Nature

56. GRAHAM F
    Daily briefing: World's first AI-designed viruses attack antibiotic-resistant bacteria.
    Nature. 2025 Sep 22. doi: 10.1038/d41586-025-03106.
    

    >> Share

    
    

    
    PLoS One

57. DISASTRA Y, Wongsurawat T, Jenjaroenpun P, Hampson DJ, et al
    Integrative genomic characterization of five Pediococcus acidilactici strains reveals differing probiotic safety profiles.
    PLoS One. 2025;20:e0332506.
    

    >> Share

    
    
58. ABEBE AA, Birhanu AG, Tessema TS
    Isolation, purification, and phenotypic characterization of virulent Klebsiella pneumoniae phages from environmental samples in Addis Ababa, Ethiopia: A synergistic approach combining spot assay and streak plating.
    PLoS One. 2025;20:e0331955.
    

    >> Share

    
    

    
    Proc Natl Acad Sci U S A

59. SHEN LQ, Lin D, Ye YQ, Liu Y, et al
    Combined pesticide pollution enhances the dissemination of the phage-encoded antibiotic resistome in the soil under nitrogen deposition.
    Proc Natl Acad Sci U S A. 2025;122:e2516722122.
    

    >> Share

    
    
60. YANG Y, Li Y, Becker ST, Khan A, et al
    Molecular basis of SARS-CoV-2 proofreading enzyme-mediated resistance to remdesivir.
    Proc Natl Acad Sci U S A. 2025;122:e2519755122.
    

    >> Share

    
    
61. CARD KJ, Crozier D, Durmaz A, Gray J, et al
    Evolution under vancomycin selection drives divergent collateral sensitivity patterns in Staphylococcus aureus.
    Proc Natl Acad Sci U S A. 2025;122:e2507962122.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share